Acadian Asset Management LLC Raises Holdings in Lifevantage Corporation $LFVN

Key Points

• Acadian Asset Management LLC increased its holdings in Lifevantage Corporation by 47.3%, owning approximately 2.32% of the company valued at $4.25 million.
• Lifevantage recently declared a quarterly dividend of $0.045 per share, with a yield of 1.6% and a payout ratio of 24.32%.
• Following a recent earnings report, Lifevantage achieved an EPS of $0.17, matching consensus expectations, but revenue was below projections at $55.11 million.

Acadian Asset Management LLC boosted its holdings in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 47.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 291,700 shares of the company's stock after buying an additional 93,661 shares during the quarter. Acadian Asset Management LLC owned approximately 2.32% of Lifevantage worth $4,248,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Cubist Systematic Strategies LLC purchased a new position in Lifevantage during the first quarter valued at approximately $97,000. Brown Advisory Inc. purchased a new position in Lifevantage during the first quarter valued at approximately $150,000. Cannon Global Investment Management LLC purchased a new position in Lifevantage during the first quarter valued at approximately $156,000. State of Wyoming purchased a new position in Lifevantage during the first quarter valued at approximately $173,000. Finally, XTX Topco Ltd purchased a new position in Lifevantage during the first quarter valued at approximately $186,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Lifevantage Trading Down 5.0%

NASDAQ:LFVN opened at $11.13 on Monday. Lifevantage Corporation has a 12 month low of $9.77 and a 12 month high of $27.38. The firm has a fifty day simple moving average of $12.98 and a 200-day simple moving average of $13.42. The company has a market capitalization of $141.24 million, a P/E ratio of 15.04 and a beta of 0.39.

Lifevantage (NASDAQ:LFVN - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. Lifevantage had a net margin of 4.29% and a return on equity of 33.75%. The business had revenue of $55.11 million during the quarter, compared to the consensus estimate of $57.93 million. During the same period in the previous year, the firm posted $0.14 earnings per share. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Monday, September 8th will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Monday, September 8th. Lifevantage's payout ratio is presently 24.32%.

Insider Buying and Selling at Lifevantage

In other news, Director Michael A. Beindorff sold 4,125 shares of Lifevantage stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $11.44, for a total transaction of $47,190.00. Following the completion of the sale, the director directly owned 22,858 shares in the company, valued at approximately $261,495.52. The trade was a 15.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Carl Aure sold 2,746 shares of Lifevantage stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $13.39, for a total transaction of $36,768.94. Following the sale, the chief financial officer owned 133,303 shares of the company's stock, valued at $1,784,927.17. The trade was a 2.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,071 shares of company stock valued at $86,229 over the last quarter. Insiders own 20.65% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wall Street Zen downgraded shares of Lifevantage from a "strong-buy" rating to a "buy" rating in a research note on Saturday, September 6th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $30.50.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lifevantage Corporation (NASDAQ:LFVN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.